A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine

被引:18
作者
Nagy, Ferenc
Molnar, Tamas
Makula, Eva
Kiss, Ildiko
Milassin, Peter
Zollei, Eva
Tiszlavicz, Laszlo
Lonovics, Janos
机构
[1] Univ Szeged, Fac Med, Dept Med 1, H-6701 Szeged, Hungary
[2] Univ Szeged, Fac Med, Dept Radiol, H-6701 Szeged, Hungary
[3] Univ Szeged, Fac Med, Med Intens Care Unit, H-6701 Szeged, Hungary
[4] Univ Szeged, Fac Med, Inst Pathol, H-6701 Szeged, Hungary
关键词
inflammatory bowel disease; ulcerative colitis; azathioprine; interstitial pneumonitis;
D O I
10.3748/wjg.v13.i2.316
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The early hypersensitivity reaction and late bone marrow depression are well-known side-effects of azathioprine, whereas interstitial pneumonia is a rare complication. A 40-year old male patient had been treated with azathioprine in consequence of extensive ulcerative colitis for 10 years. He then complained of 7 d of fever, cough and catarrhal signs, without symptoms of active colitis. Opportunistic infections were ruled out. The chest X-ray, CT and lung biopsy demonstrated the presence of interstitial inflammation. Azathioprine therapy was discontinued as a potential source of the pulmonary infiltrate. In response to steroid therapy, and intensive care, the pulmonary infiltrate gradually decreased within 4 wk. Three months later, his ulcerative colitis relapsed, and ileo-anal pouch surgery was performed. In cases of atypical pneumonia, without a proven infection , azathioprine-associated interstitial pneumonitis may be present, which heals after withdrawal of the drug. (c) 2007 The WIG Press. All rights reserved.
引用
收藏
页码:316 / 319
页数:4
相关论文
共 8 条
[1]
AZATHIOPRINE-ASSOCIATED INTERSTITIAL PNEUMONITIS [J].
BEDROSSIAN, CWM ;
SUSSMAN, J ;
CONKLIN, RH ;
KAHAN, B .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 82 (02) :148-154
[2]
Guidelines for the management of inflammatory bowel disease in adults [J].
Carter, MJ ;
Lobo, AJ ;
Travis, SPL .
GUT, 2004, 53 :v1-v16
[3]
Inflammatory bowel disease:: Current therapeutic options [J].
Domènech, E .
DIGESTION, 2006, 73 :67-76
[4]
Azathioprine, 6-Mercaptopurine in Inflammatory Bowel Disease: Pharmacology, Efficacy, and Safety [J].
Dubinsky, Marla C. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (09) :731-743
[5]
RANDOMIZED CONTROLLED TRIAL OF AZATHIOPRINE WITHDRAWAL IN ULCERATIVE-COLITIS [J].
HAWTHORNE, AB ;
LOGAN, RFA ;
HAWKEY, CJ ;
FOSTER, PN ;
AXON, ATR ;
SWARBRICK, ET ;
SCOTT, BB ;
LENNARDJONES, JE .
BRITISH MEDICAL JOURNAL, 1992, 305 (6844) :20-22
[6]
Nagy Ferenc, 2002, Orvosi Hetilap, V143, P2763
[7]
Review article: practical management of inflammatory bowel disease patients taking immunomodulators [J].
Siegel, CA ;
Sands, BE .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (01) :1-16
[8]
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes [J].
Tiede, I ;
Fritz, G ;
Strand, S ;
Poppe, D ;
Dvorsky, R ;
Strand, D ;
Lehr, HA ;
Wirtz, S ;
Becker, C ;
Atreya, R ;
Mudter, J ;
Hildner, K ;
Bartsch, B ;
Holtmann, M ;
Blumberg, R ;
Walczak, H ;
Iven, H ;
Galle, PR ;
Ahmadian, MR ;
Neurath, MF .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08) :1133-1145